1,1-Dicyclohexyl-3-(5-formyl-thiazol-2-yl)-urea → HCID 57883518, compound
Reaction equation
[CH:1]1([N:7]([CH:18]2[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]2)[C:8]([NH:10][C:11]2[S:12][C:13]([CH:16]=O)=[CH:14][N:15]=2)=[O:9])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.Cl.C([O:32][C:33]([CH:35]1[O:40][CH2:39][CH2:38][NH:37][CH2:36]1)=[O:34])C1C=CC=CC=1>>[CH:18]1([N:7]([CH:1]2[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]2)[C:8](=[O:9])[NH:10][C:11]2[S:12][C:13]([CH2:16][N:37]3[CH2:38][CH2:39][O:40][CH:35]([C:33]([OH:34])=[O:32])[CH2:36]3)=[CH:14][N:15]=2)[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]1Participants
3
Procedure
Prepared 11 mg (58%) following the general procedures (P) and (F) using 1,1-dicyclohexyl-3-(5-formyl-thiazol-2-yl)-urea (70 mg. 0.21 mmol) and morpholine-2-carboxylic acid benzyl ester hydrochloride (77 mg, 0.30 mmol).
Workup
- customPrepared 11 mg (58%)
Sources & evidence
- ORD record
- ord-933090e0c6a54526b4abee1b0f1a7828
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07851636B2
Reaction notes
Loading…